FDA Inspection 1304624 — East Coast Infertility and IVF PC
The FDA completed an inspection of East Coast Infertility and IVF PC on February 18, 2026 in Shrewsbury, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 18, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Shrewsbury, NJ (United States)